- Home
- LTH vs PRCT Comparison
LTH vs PRCT Comparison
Compare LTH & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTH
- PRCT
- Stock Information
- Founded
- LTH 1992
- PRCT 2009
- Country
- LTH United States
- PRCT United States
- Employees
- LTH N/A
- PRCT N/A
- Industry
- LTH Hotels/Resorts
- PRCT Medical Specialities
- Sector
- LTH Consumer Discretionary
- PRCT Health Care
- Exchange
- LTH Nasdaq
- PRCT Nasdaq
- Market Cap
- LTH 4.9B
- PRCT 5.3B
- IPO Year
- LTH 2021
- PRCT 2021
- Fundamental
- Price
- LTH $23.72
- PRCT $88.94
- Analyst Decision
- LTH Buy
- PRCT Strong Buy
- Analyst Count
- LTH 10
- PRCT 6
- Target Price
- LTH $26.10
- PRCT $89.50
- AVG Volume (30 Days)
- LTH 1.3M
- PRCT 1.3M
- Earning Date
- LTH 10-24-2024
- PRCT 10-28-2024
- Dividend Yield
- LTH N/A
- PRCT N/A
- EPS Growth
- LTH 106.19
- PRCT N/A
- EPS
- LTH 0.68
- PRCT N/A
- Revenue
- LTH $2,516,546,000.00
- PRCT $199,843,000.00
- Revenue This Year
- LTH $18.38
- PRCT $67.06
- Revenue Next Year
- LTH $9.45
- PRCT $40.59
- P/E Ratio
- LTH $34.81
- PRCT N/A
- Revenue Growth
- LTH 18.12
- PRCT 71.71
- 52 Week Low
- LTH $11.89
- PRCT $31.57
- 52 Week High
- LTH $27.12
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- LTH 46.62
- PRCT 52.97
- Support Level
- LTH $23.81
- PRCT $85.75
- Resistance Level
- LTH $25.60
- PRCT $103.81
- Average True Range (ATR)
- LTH 0.66
- PRCT 5.83
- MACD
- LTH 0.06
- PRCT -0.70
- Stochastic Oscillator
- LTH 43.44
- PRCT 17.66
About LTH Life Time Group Holdings Inc.
Life Time Group Holdings Inc is a lifestyle brand offering health, fitness and wellness experiences to a community. It is engaged in designing, building, and operating distinctive and large, multi-use sports and athletic, professional fitness, family recreation and spa centers in a resort-like environment, principally in residential locations of metropolitan areas in the United States and Canada.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.